Nexpoint Asset Management’s Elevance Health ELV Stock Holding History

Nexpoint Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,300	Closed	-$1.53M	–	185
2021 Q4	$1.53M	Buy	3,300 +1,885	+133%	+$793K	0.22%	67
2021 Q3	$528K	Buy	1,415 +446	+46%	+$169K	0.09%	106
2021 Q2	$370K	Sell	969 -2,041	-68%	-$780K	0.08%	113
2021 Q1	$1.08M	Sell	3,010 -1,490	-33%	-$479K	0.28%	56
2020 Q4	$1.45M	Buy	4,500 +500	+13%	+$153K	0.48%	53
2020 Q3	$1.07M	Hold	4,000	–	–	0.24%	72
2020 Q2	$1.05M	Sell	4,000 -250	-6%	-$66.7K	0.24%	72
2020 Q1	$965K	Buy	4,250 +750	+21%	+$204K	0.18%	76
2019 Q4	$1.06M	Hold	3,500	–	–	0.08%	139
2019 Q3	$840K	Buy	+3,500	New	+$959K	0.05%	214

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Nexpoint Asset Management's ELV Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 3,300 shares — an estimated $1.53M sold.

Nexpoint Asset Management first reported a position in ELV in Q3 2019 and held it in 10 quarters. The position peaked at $1.53M in Q4 2021. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

Nexpoint Asset Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
Nexpoint Asset Management sold 3,300 Elevance Health shares in Q1 2022, an estimated $1.53M.
Nexpoint Asset Management first reported a position in Elevance Health in Q3 2019 and held it in 10 quarters.
Nexpoint Asset Management's Elevance Health position peaked at $1.53M in Q4 2021.
1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.